Clinical trials
Cardiovascular Diseases trials in Sweden
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
117 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 4 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 5 |
| 2009 | 6 |
| 2010 | 5 |
| 2011 | 4 |
| 2012 | 7 |
| 2013 | 6 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 8 |
| 2017 | 6 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 6 |
| 2023 | 8 |
| 2024 | 8 |
| 2025 | 7 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 59 |
| Recruiting | 23 |
| Active, not recruiting | 11 |
| Terminated | 11 |
| Enrolling by invitation | 8 |
| Unknown status | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Karolinska Institutet | 11 |
| AstraZeneca | 6 |
| Novartis Pharmaceuticals | 5 |
| Region Skane | 5 |
| University Hospital, Linkoeping | 5 |
| Abbott Medical Devices | 4 |
| Lund University | 4 |
| Pfizer | 4 |
| Umeå University | 4 |
| Uppsala University | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 117 |
| Hypertension | 18 |
| Heart Diseases | 15 |
| Myocardial Infarction | 13 |
| Stroke | 13 |
| Diabetes Mellitus, Type 2 | 11 |
| Coronary Artery Disease | 9 |
| Diabetes Mellitus | 8 |
| Vascular Diseases | 8 |
| Atherosclerosis | 7 |
Trials
Showing 76 to 100 of 117. Each trial links to its page on Pharma Observatory.
17 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.